Aquestive Therapeutics (AQST) Current Leases (2020 - 2025)
Historic Current Leases for Aquestive Therapeutics (AQST) over the last 6 years, with Q3 2025 value amounting to $601000.0.
- Aquestive Therapeutics' Current Leases rose 2468.88% to $601000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $601000.0, marking a year-over-year increase of 2468.88%. This contributed to the annual value of $510000.0 for FY2024, which is 3076.92% up from last year.
- According to the latest figures from Q3 2025, Aquestive Therapeutics' Current Leases is $601000.0, which was up 2468.88% from $570000.0 recorded in Q2 2025.
- In the past 5 years, Aquestive Therapeutics' Current Leases registered a high of $926000.0 during Q1 2022, and its lowest value of $255000.0 during Q4 2022.
- Moreover, its 5-year median value for Current Leases was $540000.0 (2025), whereas its average is $595421.1.
- As far as peak fluctuations go, Aquestive Therapeutics' Current Leases plummeted by 7163.52% in 2022, and later soared by 5294.12% in 2023.
- Over the past 5 years, Aquestive Therapeutics' Current Leases (Quarter) stood at $899000.0 in 2021, then crashed by 71.64% to $255000.0 in 2022, then skyrocketed by 52.94% to $390000.0 in 2023, then surged by 30.77% to $510000.0 in 2024, then rose by 17.84% to $601000.0 in 2025.
- Its Current Leases stands at $601000.0 for Q3 2025, versus $570000.0 for Q2 2025 and $540000.0 for Q1 2025.